ArticleOncoTargets and therapy2014

Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation.

Antonio Ieni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.